Compass Financial Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Compass Financial Management's MRNA Position: Q3 2026 in Review
Compass Financial Management increased its Moderna (MRNA) stake by 1.9% in Q3 2026, buying an estimated $108 and bringing the position to 53 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.
Compass Financial Management first reported a position in MRNA in Q2 2026 and has held it in 2 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Compass Financial Management held 53 shares of Moderna worth $10.2K as of Q3 2026.
- Compass Financial Management bought 1 Moderna share in Q3 2026, an estimated $108.
- Moderna made up ﹤0.01% of Compass Financial Management's portfolio in Q3 2026, its #1121 holding.
- Compass Financial Management first reported a position in Moderna in Q2 2026 and has held it in 2 quarters since.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.